Large Extent of Disorder in Adenomatous Polyposis Coli Offers a Strategy to Guard Wnt Signalling against Point Mutations

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Minde, David P ^a   Radli, Martina ^a   Forneris, Federico ^a   Maurice, Madelon M ^b   Rüdiger, Stefan G D ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE BB; CREATINE KINASE BB EPSILON; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; CAENORHABDITIS ELEGANS; COLON POLYPOSIS; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DISEASE ACTIVITY; GEL PERMEATION CHROMATOGRAPHY; GENE CLUSTER; GENE STRUCTURE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; POINT MUTATION; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; PROTEIN UNFOLDING; REGULATORY MECHANISM; STRUCTURE ANALYSIS; WNT SIGNALING PATHWAY;

ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; HOT TEMPERATURE; HUMANS; MUTATION; PHOSPHORYLATION; POINT MUTATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN UNFOLDING; PROTEOLYSIS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84885167144     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077257     Document Type: Article

References (70)

1. Kinzler KW, Vogelstein B, (1996) Lessons from hereditary colorectal cancer. Cell 87: 159-170. doi:10.1016/S0092-8674(00)81333-1. PubMed: 8861899.
2. Aoki K, Taketo MM, (2007) Adenomatous polyposis coli (APC): A multi-functional tumor suppressor gene. J Cell Sci 120: 3327-3335. doi:10.1242/jcs.03485. PubMed: 17881494.
3. McCartney BM, Näthke IS, (2008) Cell regulation by the apc protein apc as master regulator of epithelia. Curr Opin Cell Biol 20: 186-193. doi:10.1016/j.ceb.2008.02.001. PubMed: 18359618.
4. Roberts DM, Pronobis MI, Poulton JS, Waldmann JD, Stephenson EM, et al. (2011) Deconstructing the sscatenin destruction complex: Mechanistic roles for the tumor suppressor APC in regulating wnt signaling. Mol Cell Biol 22: 1845-1863. doi:10.1091/mbc.E10-11-0871.
5. Rubinfeld B, Souza B, Albert I, Müller O, Chamberlain SH, et al. (1993) Association of the APC gene product with beta-catenin. Science 262: 1731-1734. doi:10.1126/science.8259518. PubMed: 8259518.
6. Su LK, Vogelstein B, Kinzler KW, (1993) Association of the APC tumor suppressor protein with catenins. Science 262: 1734-1737. doi:10.1126/science.8259519. PubMed: 8259519.
7. Behrens J, Jerchow BA, Würtele M, Grimm J, Asbrand C, et al. (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280: 596-599. doi:10.1126/science.280.5363.596. PubMed: 9554852.
8. Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, et al. (1998) Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin. J Biol Chem 273: 10823-10826. doi:10.1074/jbc.273.18.10823. PubMed: 9556553.
9. Nakamura T, Hamada F, Ishidate T, Anai K, Kawahara K, et al. (1998) Axin, an inhibitor of the wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level. Genes Cells 3: 395-403. doi:10.1046/j.1365-2443.1998.00198.x. PubMed: 9734785.
10. Spink KE, Polakis P, Weis WI, (2000) Structural basis of the axin-adenomatous polyposis coli interaction. EMBO J 19: 2270-2279. doi:10.1093/emboj/19.10.2270. PubMed: 10811618.
11. Eklof Spink K, Fridman SG, Weis WI, (2001) Molecular mechanisms of beta-catenin recognition by adenomatous polyposis coli revealed by the structure of an APC-beta-catenin complex. EMBO J 20: 6203-6212. doi:10.1093/emboj/20.22.6203. PubMed: 11707392.
12. Ha NC, Tonozuka T, Stamos JL, Choi HJ, Weis WI, (2004) Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation. Mol Cell 15: 511-521. doi:10.1016/j.molcel.2004.08.010. PubMed: 15327768.
13. Boutet A, Comai G, Schedl A, (2010) The WTX/AMER1 gene family: Evolution, signature and function. BMC Evol Biol 10280:: 280-. doi:10.1186/1471-2148-10-280. PubMed: 20843316.
14. Tanneberger K, Pfister AS, Brauburger K, Schneikert J, Hadjihannas MV, et al. (2011) 1/WTX couples wnt-induced formation of PtdIns(4,5). AmerP2to LRP6 phosphorylation. EMBO J 30: 1433-1443 doi:10.1038/emboj.2011.28.
15. Hilger M, Mann M, (2012) Triple SILAC to determine stimulus specific interactions in the wnt pathway. J Proteome Res 11: 982-994. doi:10.1021/pr200740a. PubMed: 22011079.
16. Li VS, Ng SS, Boersema PJ, Low TY, Karthaus WR, et al. (2012) Wnt signaling through inhibition of beta-catenin degradation in an intact Axin1 complex. Cell 149: 1245-1256. doi:10.1016/j.cell.2012.05.002. PubMed: 22682247.
17. Gaspar C, Fodde R, (2004) APC dosage effects in tumorigenesis and stem cell differentiation. Int J Dev Biol 48: 377-386. doi:10.1387/ijdb.041807cg. PubMed: 15349813.
18. Minde DP, Anvarian Z, Rüdiger SGD, Maurice MM, (2011) Messing up disorder: How do missense mutations in the tumor suppressor protein APC lead to cancer? Mol Cancer 10101:: 101-. doi:10.1186/1476-4598-10-101. PubMed: 21859464.
19. Xing Y, Clements WK, Le Trong I, Hinds TR, Stenkamp R, et al. (2004) Crystal structure of a beta-catenin/APC complex reveals a critical role for APC phosphorylation in APC function. Mol Cell 15: 523-533. doi:10.1016/j.molcel.2004.08.001. PubMed: 15327769.
20. Liu J, Xing Y, Hinds TR, Zheng J, Xu W, (2006) The third 20 amino acid repeat is the tightest binding site of APC for beta-catenin. J Mol Biol 360: 133-144. doi:10.1016/j.jmb.2006.04.064. PubMed: 16753179.
21. Ferrarese A, Marin O, Bustos VH, Venerando A, Antonelli M, et al. (2007) Chemical dissection of the APC repeat 3 multistep phosphorylation by the concerted action of protein kinases CK1 and GSK3. Biochemistry 46: 11902-11910. doi:10.1021/bi701674z. PubMed: 17910481.
22. Tickenbrock L, Cramer J, Vetter IR, Muller O, (2002) The coiled coil region (amino acids 129-250) of the tumor suppressor protein adenomatous polyposis coli (APC). its structure and its interaction with chromosome maintenance region 1 (crm-1). J Biol Chem 277: 32332-32338. doi:10.1074/jbc.M203990200. PubMed: 12070164.
23. Morishita EC, Murayama K, Kato-Murayama M, Ishizuka-Katsura Y, Tomabechi Y, et al. (2011) Crystal structures of the armadillo repeat domain of adenomatous polyposis coli and its complex with the tyrosine-rich domain of Sam68. Structure 19: 1496-1508. doi:10.1016/j.str.2011.07.013. PubMed: 22000517.
24. Zhang Z, Chen L, Gao L, Lin K, Zhu L, et al. (2012) Structural basis for the recognition of asef by adenomatous polyposis coli. Cell Res 22: 372-386. doi:10.1038/cr.2011.119. PubMed: 21788986; Retrieved onpublished at whilst December year 1111 from. doi:10.1038/cr.2011.119.
25. Zhang Z, Lin K, Gao L, Chen L, Shi X, et al. (2011) Crystal structure of the armadillo repeat domain of adenomatous polyposis coli which reveals its inherent flexibility. Biochem Biophys Res Commun 412: 732-736. doi:10.1016/j.bbrc.2011.08.044. PubMed: 21871439.
26. Day CL, Alber T, (2000) Crystal structure of the amino-terminal coiled-coil domain of the APC tumor suppressor. J Mol Biol 301: 147-156. doi:10.1006/jmbi.2000.3895. PubMed: 10926498.
27. Azzopardi D, Dallosso AR, Eliason K, Hendrickson BC, Jones N, et al. (2008) Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas. Cancer Res 68: 358-363. doi:10.1158/0008-5472.CAN-07-5733. PubMed: 18199528.
28. Kohler EM, Derungs A, Daum G, Behrens J, Schneikert J, (2008) Functional definition of the mutation cluster region of adenomatous polyposis coli in colorectal tumours. Hum Mol Genet 17: 1978-1987. doi:10.1093/hmg/ddn095. PubMed: 18387968.
29. Xue B, Dunker AK, Uversky VN, (2012) The roles of intrinsic disorder in orchestrating the wnt-pathway. J Biomol Struct Dyn 29: 843-861. doi:10.1080/073911012010525024. PubMed: 22292947.
30. Marsh JA, Forman-Kay JD, (2010) Sequence determinants of compaction in intrinsically disordered proteins. Biophys J 98: 2383-2390. doi:10.1016/j.bpj.2010.02.006. PubMed: 20483348.
31. Müller-Späth S, Soranno A, Hirschfeld V, Hofmann H, Rüegger S, et al. (2010) From the cover: Charge interactions can dominate the dimensions of intrinsically disordered proteins. Proc Natl Acad Sci U S A 107: 14609-14614. doi:10.1073/pnas.1001743107. PubMed: 20639465.
32. Bark SJ, Muster N, Yates JR 3rd, Siuzdak G, (2001) High-temperature protein mass mapping using a thermophilic protease. J Am Chem Soc 123: 1774-1775. doi:10.1021/ja002909n. PubMed: 11456785.
33. Jones S, Thornton JM, (1996) Principles of protein-protein interactions. Proc Natl Acad Sci U S A 93: 13-20. doi:10.1073/pnas.93.1.13. PubMed: 8552589.
34. Kurnik M, Hedberg L, Danielsson J, Oliveberg M, (2012) Folding without charges. Proc Natl Acad Sci U S A 109: 5705-5710. doi:10.1073/pnas.1118640109. PubMed: 22454493.
35. Park C, Marqusee S, (2005) Pulse proteolysis: A simple method for quantitative determination of protein stability and ligand binding. Nat Methods 2: 207-212. doi:10.1038/nmeth740. PubMed: 15782190.
36. Minde DP, Maurice MM, Rüdiger SGD, (2012) Determining biophysical protein stability in lysates by a fast proteolysis assay, FASTpp. PLOS ONE 7: e46147. doi:10.1371/journal.pone.0046147. PubMed: 23056252; Retrieved onpublished at whilst December year 1111 from. doi:10.1371/journal.pone.0046147.
37. Noutsou M, Duarte AM, Anvarian Z, Didenko T, Minde DP, et al. (2011) Critical scaffolding regions of the tumor suppressor Axin1 are natively unfolded. J Mol Biol 405: 773-786. doi:10.1016/j.jmb.2010.11.013. PubMed: 21087614.
38. Alexandrescu AT, Ng YL, Dobson CM, (1994) Characterization of a trifluoroethanol-induced partially folded state of alpha-lactalbumin. J Mol Biol 235: 587-599. doi:10.1006/jmbi.1994.1015. PubMed: 8289283.
39. Quint S, Widmaier S, Minde D, Hornburg D, Langosch D, et al. (2010) Residue-specific side-chain packing determines the backbone dynamics of transmembrane model helices. Biophys J 99: 2541-2549. doi:10.1016/j.bpj.2010.08.031. PubMed: 20959095.
40. Yiu CP, Mateu MG, Fersht AR, (2000) Protein folding transition states: Elicitation of hammond effects by febbraio,2,2-trifluoroethanol. Chembiochem 1: 49-55. doi:10.1002/1439-7633(20000703)1:1. PubMed: 11828398.
41. Besley NA, Hirst JD, (1999) Theoretical studies toward quantitative protein circular dichroism calculations. J Am Chem Soc 121: 9636-9644. Available: http://dx.doi.org/10.1021/ja990627l via the Internet.
42. Muñoz V, Thompson PA, Hofrichter J, Eaton WA, (1997) Folding dynamics and mechanism of beta-hairpin formation. Nature 390196-199:: 196-9. doi:10.1038/36626. PubMed: 9367160.
43. Gnad F, Ren S, Cox J, Olsen JV, Macek B, et al. (2007) PHOSIDA (phosphorylation site database): Management, structural and evolutionary investigation, and prediction of phosphosites. Genome Biol 8R250:: R250-. doi:10.1186/gb-2007-8-11-r250. PubMed: 18039369.
44. Kinoshita E, Kinoshita-Kikuta E, Koike T, (2009) Separation and detection of large phosphoproteins using phos-tag SDS-PAGE. Nat Protoc 4: 1513-1521. doi:10.1038/nprot.2009.154. PubMed: 19798084.
45. Kinoshita E, Kinoshita-Kikuta E, Matsubara M, Yamada S, Nakamura H, et al. (2008) Separation of phosphoprotein isotypes having the same number of phosphate groups using phosphate-affinity SDS-PAGE. Proteomics 8: 2994-3003. doi:10.1002/pmic.200800243. PubMed: 18615432.
46. Kinoshita E, Kinoshita-Kikuta E, Takiyama K, Koike T, (2006) Phosphate-binding tag, a new tool to visualize phosphorylated proteins. Mol Cell Proteomics 5: 749-757. doi:10.1074/mcp.T500024-MCP200. PubMed: 16340016.
47. Dahlberg CL, Nguyen EZ, Goodlett D, Kimelman D, (2009) Interactions between casein kinase iepsilon (CKIepsilon) and two substrates from disparate signaling pathways reveal mechanisms for substrate-kinase specificity. PLOS ONE 4: e4766. doi:10.1371/journal.pone.0004766. PubMed: 19274088.
48. Xue B, Dunbrack RL, Williams RW, Dunker AK, Uversky VN, (2010) PONDR-FIT: A meta-predictor of intrinsically disordered amino acids. Biochim Biophys Acta 1804: 996-1010. doi:10.1016/j.bbapap.2010.01.011. PubMed: 20100603.
49. Taipale M, Jarosz DF, Lindquist S, (2010) HSP90 at the hub of protein homeostasis: Emerging mechanistic insights. Nat Rev Mol Cell Biol 11: 515-528. doi:10.1038/nrm2918. PubMed: 20531426.
50. Reverter D, Lima CD, (2005) Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature 435: 687-692. doi:10.1038/nature03588. PubMed: 15931224.
51. Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP, (2009) Awakening guardian angels: Drugging the p53 pathway. Nat Rev Cancer 9: 862-873. doi:10.1038/nrc2763. PubMed: 19935675.
52. Joerger AC, Fersht AR, (2008) Structural biology of the tumor suppressor p53. Annu Rev Biochem 77: 557-582. doi:10.1146/annurev.biochem.77.060806.091238. PubMed: 18410249.
53. Brüschweiler S, Schanda P, Kloiber K, Brutscher B, Kontaxis G, et al. (2009) Direct observation of the dynamic process underlying allosteric signal transmission. J Am Chem Soc 131: 3063-3068. doi:10.1021/ja809947w. PubMed: 19203263.
54. Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, et al. (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291: 2423-2428. doi:10.1126/science.1056784. PubMed: 11264541.
55. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71. doi:10.1126/science.7545954. PubMed: 7545954.
56. Uversky VN, Oldfield CJ, Dunker AK, (2008) Intrinsically disordered proteins in human diseases: Introducing the D2 concept. Annu Rev Biophys 37: 215-246. doi:10.1146/annurev.biophys.37.032807.125924. PubMed: 18573080.
57. Shibata N, Tomimoto Y, Hanamura T, Yamamoto R, Ueda M, et al. (2007) Crystallization and preliminary X-ray crystallographic studies of the axin DIX domain. Acta Crystallogr Sect Struct Biol Cryst Commun 63529-531:: 529-31. doi:10.1107/S1744309107022579. PubMed: 17554179.
58. Uversky VN, Dunker AK, (2010) Understanding protein non-folding. Biochim Biophys Acta 1804: 1231-1264. doi:10.1016/j.bbapap.2010.01.017. PubMed: 20117254.
59. Xue B, Dunker AK, Uversky VN, (2012) Orderly order in protein intrinsic disorder distribution: Disorder in 3500 proteomes from viruses and the three domains of life. J Biomol Struct Dyn 30: 137-149. doi:10.1080/07391102.2012.675145. PubMed: 22702725.
60. Balázs A, Csizmok V, Buday L, Rakács M, Kiss R, et al. (2009) High levels of structural disorder in scaffold proteins as exemplified by a novel neuronal protein, CASK-interactive protein1. FEBS J 276: 3744-3756. doi:10.1111/j.1742-4658.2009.07090.x. PubMed: 19523119; Retrieved onpublished at whilst December year 1111 from.
61. Cortese MS, Uversky VN, Keith Dunker A, (2008) Intrinsic disorder in scaffold proteins: Getting more from less. Prog Biophys Mol Biol 98: 85-106: 85-106. 23 September 2009 PubMed: 18619997.
62. Schlessinger A, Schaefer C, Vicedo E, Schmidberger M, Punta M, et al. (2011) Protein disorder--a breakthrough invention of evolution? Curr Opin Struct Biol 21: 412-418. doi:10.1016/j.sbi.2011.03.014. PubMed: 21514145.
63. Schaefer C, Schlessinger A, Rost B, (2010) Protein secondary structure appears to be robust under in silico evolution while protein disorder appears not to be. Bioinformatics 26: 625-631. doi:10.1093/bioinformatics/btq012. PubMed: 20081223.
64. Tickenbrock L, Kössmeier K, Rehmann H, Herrmann C, Müller O, (2003) Differences between the interaction of beta-catenin with non-phosphorylated and single-mimicked phosphorylated 20-amino acid residue repeats of the APC protein. J Mol Biol 327: 359-367. doi:10.1016/S0022-2836(03)00144-X. PubMed: 12628243.
65. Xing Y, Takemaru K, Liu J, Berndt JD, Zheng JJ, et al. (2008) Crystal structure of a full-length beta-catenin. Structure 16: 478-487. doi:10.1016/j.str.2007.12.021. PubMed: 18334222.
66. Xue B, Romero PR, Noutsou M, Maurice MM, Rüdiger SGD, et al. (2013) Stochastic machines as a colocalization mechanism for scaffold protein function. FEBS Lett 587: 1587-1591. doi:10.1016/j.febslet.2013.04.006. PubMed: 23603389; Retrieved onpublished at whilst December year 1111 from.
67. Dunker AK, Silman I, Uversky VN, Sussman JL, (2008) Function and structure of inherently disordered proteins. Curr Opin Struct Biol 18: 756-64: 756-764. 23 September 2009 PubMed: 18952168.
68. Foldynová-Trantírková S, Sekyrová P, Tmejová K, Brumovská E, Bernatík O, et al. (2010) Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration. Breast Cancer Res 12R30:: R30-. doi:10.1186/bcr2581. PubMed: 20507565.
69. Luo S, Wehr NB, Levine RL, (2006) Quantitation of protein on gels and blots by infrared fluorescence of coomassie blue and fast green. Anal Biochem 350: 233-238. doi:10.1016/j.ab.2005.10.048. PubMed: 16336940.
70. Kohler EM, Chandra SH, Behrens J, Schneikert J, (2009) Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours. Hum Mol Genet 18: 213-226. doi:10.1093/hmg/ddn338. PubMed: 18854359.